41 related articles for article (PubMed ID: 22776928)
1. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
[TBL] [Abstract][Full Text] [Related]
3. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma.
Ansari H; Kempen JH
Am J Ophthalmol; 2010 May; 149(5):699-700. PubMed ID: 20399922
[No Abstract] [Full Text] [Related]
4. Validation of a photographic vitreous haze grading technique for clinical trials in uveitis.
Madow B; Galor A; Feuer WJ; Altaweel MM; Davis JL
Am J Ophthalmol; 2011 Aug; 152(2):170-176.e1. PubMed ID: 21652026
[TBL] [Abstract][Full Text] [Related]
5. Optimizing glucocorticoid therapy for Behçet's uveitis: efficacy, adverse effects, and advances in combination approaches.
Li B; Li H; Huang Q; Zheng Y
Int Ophthalmol; 2023 Nov; 43(11):4373-4381. PubMed ID: 37420127
[TBL] [Abstract][Full Text] [Related]
6. A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future.
Conrady CD; Yeh S
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452185
[TBL] [Abstract][Full Text] [Related]
7. Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma.
Nguyen T; Kim H; Mielke C; Momont AC; Brandt JD; Liu Y
J Glaucoma; 2020 Apr; 29(4):252-257. PubMed ID: 31990825
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma.
Sevgi DD; Davoudi S; Talcott KE; Cho H; Guo R; Lobo AM; Papaliodis GN; Turalba A; Sobrin L; Shen LQ
Digit J Ophthalmol; 2017; 23(3):63-70. PubMed ID: 29162989
[TBL] [Abstract][Full Text] [Related]
9. Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy.
Cham A; Bansal M; Banda HK; Kwon Y; Tlucek PS; Bassuk AG; Tsang SH; Sobol WM; Folk JC; Yeh S; Mahajan VB
Clin Ophthalmol; 2016; 10():1187-97. PubMed ID: 27390515
[TBL] [Abstract][Full Text] [Related]
10. Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study.
Moore DB; Stinnett S; Jaffe GJ; Asrani S
Ophthalmol Ther; 2015 Dec; 4(2):103-13. PubMed ID: 26547746
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy.
Tlucek PS; Folk JC; Sobol WM; Mahajan VB
Clin Ophthalmol; 2013; 7():1093-8. PubMed ID: 23785231
[TBL] [Abstract][Full Text] [Related]
12. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
13. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
14. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis.
Androudi S; Ahmed M; Fiore T; Brazitikos P; Foster CS
J Cataract Refract Surg; 2005 Mar; 31(3):472-8. PubMed ID: 15811733
[TBL] [Abstract][Full Text] [Related]
15. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
[TBL] [Abstract][Full Text] [Related]
16. Combined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitis.
Ahmad ZM; Hughes BA; Abrams GW; Mahmoud TH
Arch Ophthalmol; 2012 Jul; 130(7):908-13. PubMed ID: 22776928
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
